Actively Recruiting
Cohort Primary Hyperparathyroidism
Led by Nantes University Hospital · Updated on 2025-09-08
403
Participants Needed
1
Research Sites
568 weeks
Total Duration
On this page
Sponsors
N
Nantes University Hospital
Lead Sponsor
I
Institut National de la Santé Et de la Recherche Médicale, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
CoHPT is a prospective, monocentric, observational cohort including all patients diagnosed with primary hyperparathyroidism in Nantes University Hospital, aiming to study the outcomes associated with parathyroidectomy. Clinical and biochemical evaluation is performed at the inclusion, and 6, 12, 36 and 60 months. A biocollection is collected. The main hypotheses are that parathyroidectomy could improve cardiovascular, renal, bone, and cardiovascular outcomes along with quality of life.
CONDITIONS
Official Title
Cohort Primary Hyperparathyroidism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18
You will not qualify if you...
- Age < 18
- Pregnancy or breastfeeding
- Adults under guardianship
- Secondary or tertiary hyperparathyroidism
- Multiple endocrine neoplasia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nantes University Hospital
Nantes, Loire-Atlantique, France, 44093
Actively Recruiting
Research Team
E
Eric MIRALLIE, PHD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here